ALEC - Financial Reports List - Alector, Inc. - IntrinsicAlpha

Alector, Inc. ALEC

Healthcare - Biotechnology - NASDAQ - US

$ 0.9734

5.79 %

$ 96.5 M

Market Cap

-0.79

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	257.08%	94.99%	84.72%
Annual Report	FY	10-K	2024-12-31	3.60%	8.70%	4.44%
Quarterly Report	Q3	8-K	2024-09-30	68.43%	5.07%	4.25%
Quarterly Report	Q2	8-K	2024-06-30	-73.17%	-2812.80%	-1170.72%
Quarterly Report	Q1	8-K	2024-03-31	-3.96%	21.32%	12.78%
Quarterly Report	Q4	8-K	2023-12-31	5.19%	20.97%	14.40%
Annual Report	FY	10-K	2023-12-31	-27.36%	2.19%	-10.09%
Quarterly Report	Q3	8-K	2023-09-30	-38.67%	3.63%	-5.94%
Quarterly Report	Q2	8-K	2023-06-30	-29.60%	-86.09%	-37.88%
Quarterly Report	Q1	8-K	2023-03-31	-32.38%	-2.78%	-13.58%

1